Capillary Technologies grants 7.45 lakh stock options to employees
Capillary Technologies India Limited granted 7,45,537 stock options to eligible employees under its ESOP Plan 2021 on July 01, 2026. The exercise price is ₹418 per option for general employees and ₹521.47 for US tax residents. Options vest over three to four years and are exercisable within 10 years of vesting or 12 years of listing.
*this image is generated using AI for illustrative purposes only.
Capillary Technologies India Limited granted 7,45,537 stock options to eligible employees under its ESOP Plan 2021. The company's Nomination and Remuneration Committee approved the grant via a circular resolution on July 01, 2026. This move aims to incentivize employees by offering them an opportunity to participate in the company's ownership and growth.
The options are priced differently based on the tax residency of the employee. For employees who are not US tax residents or US nationals, the exercise price is ₹418 per option. This price represents a discount of 19.84% to the fair market value as approved by the committee. For employees who are residents of the United States or subject to US income taxation, the exercise price is set at the full fair market value of ₹521.47 per option.
The fair market value was calculated using the volume-weighted average price of the shares for the 90 days immediately preceding the working day prior to the grant date. This calculation was based on trading data from the stock exchange with the highest trading volume. Each stock option carries the right to apply for and be allotted one equity share of face value ₹2.
The granted options will vest over a period of three to four years, subject to the fulfilment of conditions specified in the grant letters. Once vested, the options can be exercised within 10 years from the date of vesting or 12 years from the date of listing, whichever is later. In case of resignation, all vested options must be exercised within one year from the last working day with the company.
The scheme is compliant with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. There are no variations in the terms of the options, and no options have been lapsed, exercised, or cancelled as of the grant date. The detailed information regarding the grant is available on the company's website.
Key Details of ESOP Grant
| Particulars | Details |
|---|---|
| Total Options Granted | 7,45,537 |
| Face Value | ₹2 per share |
| Exercise Price (General) | ₹418 per option |
| Discount to FMV | 19.84% |
| Exercise Price (US Tax Residents) | ₹521.47 per option |
| Vesting Period | 3 to 4 years |
Historical Stock Returns for Capillary Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.54% | +1.66% | +1.03% | -23.35% | -14.92% | -14.92% |
How will the significant discount for non-US employees impact the company's future financial liabilities and cash flow?
What is the expected retention rate impact of the 3-4 year vesting period on key talent?
Could this ESOP expansion signal an upcoming IPO or secondary fundraising round?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
